Advertisement

Atrial Natriuretic Peptides and Renin Secretion

  • E. Hackenthal
  • R. E. Lang
  • C. P. Buhrle
Chapter
  • 12 Downloads
Part of the Developments in Nephrology book series (DINE, volume 18)

Abstract

In several studies in vivo, atrial natriuretic peptides(ANP) did either not affect (1,2) or induced a moderate decrease(3,4) of renin secretion from the kidney or plasma renin concentrations. In these studies, ANP produced significant changes of systemic and intrarenal hemodynamics and renal tubular function, all of which are known to participate in the control of renin secretion. It therefore remained unclear, whether ANPs have any direct effect on renin secreting juxtaglomerular cells. We have therefore examined the influence of atrial natriuretic peptide on renin secretion from the isolated rat kidney, in which interference by neuronal, hemodynamic, humoral, and, to some extent, also tubular mechanisms can be excluded. Part of the results have been published in preliminary form(5).

Keywords

Atrial Natriuretic Peptide Renin Release Renin Secretion Juxtaglomerular Cell Plasma Renin Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Seymour, A.A., Blaine, E.H., Mazak, E.K., Smith, S.G., Stabilste, I. I., Haley, A.B., Napier, M.A., Whinnery, M.A., and Nutt, R.F., Life Sci. 36: 33–44, 1985.PubMedCrossRefGoogle Scholar
  2. 2.
    Beasley, D., and Malvin, R.L., Am. J. Physiol. 248: F24–F30, 1985.PubMedGoogle Scholar
  3. 3.
    Burnett, J.C., Granger, Jr. J.P., and Opgenorth, T.J., Am. J. Physiol. 247: F863–F866, 1984.PubMedGoogle Scholar
  4. 4.
    Maack, T., Marion, D.Í., Camargo, M. J.F., Kleinert, H.D., Laragh, J.H., Vaugham, Jr. E.D., and Atlas, S.A., Am. J. Med. 77: 1069–1075, 1984.PubMedCrossRefGoogle Scholar
  5. 5.
    Hackenthal, E., Lang, R.E., and Buhrle, C.P., J.Hypertens.3 (suppl.3): S323–S325, 1985.Google Scholar
  6. 6.
    Schwertschlag, U., and Hackenthal, E., Naunyn-Schmiedebergs Arch. Pharmacol. 319: 239–242, 1982.PubMedCrossRefGoogle Scholar
  7. 7.
    Marin-Grez, M., Briggs, J.P., Schubert, G., and Schnermann, J., Life Sci. 36: 2171–2176, 1985.PubMedCrossRefGoogle Scholar
  8. 8.
    Winquist, R.J., Faison, E.P., Waldman, S.A., Schwartz, K., Murad, F., and Rapoport, R.M., Proc.Natl.Acad.Sci. 81: 7661–7664, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • E. Hackenthal
    • 1
    • 2
  • R. E. Lang
    • 1
    • 2
  • C. P. Buhrle
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of HeidelbergHeidelbergGermany
  2. 2.Department of PhysiologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations